Delta opioid receptor


Migraines are debilitating, and there are limited therapeutics for migraines and migraine-like headaches. Delta opioid receptors (DORs) have garnered increasing interest as promising drug targets for these neurological disorders. To determine the effectiveness of DOR activation in alleviating migraine-like pain, I tested SNC80, a hallmark DOR agonist, in a variety of animal models of headache.

Read more about why the DOR is a promising drug target here.